EDGEWELL PERSONAL CARE Co: Form 10-Q for the period ended Jun 30, 2025
Filed with the SEC on Aug 5, 2025 and accepted by EDGAR at Aug 5, 2025, 16:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-04-01 to 2025-06-30 | $627.2m | us-gaap:Revenues |
| Revenue | 9 months2024-10-01 to 2025-06-30 | $1.69bn | us-gaap:Revenues |
| Cost of revenue | 3 months2025-04-01 to 2025-06-30 | $358.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-10-01 to 2025-06-30 | $970.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-04-01 to 2025-06-30 | $268.5m | us-gaap:GrossProfit |
| Gross profit | 9 months2024-10-01 to 2025-06-30 | $716.3m | us-gaap:GrossProfit |
| Research and development | 3 months2025-04-01 to 2025-06-30 | $14.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-10-01 to 2025-06-30 | $41.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-04-01 to 2025-06-30 | $104.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-10-01 to 2025-06-30 | $313.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-04-01 to 2025-06-30 | $53.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-10-01 to 2025-06-30 | $132.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-04-01 to 2025-06-30 | $19.4m | us-gaap:InterestExpense |
| Interest expense | 9 months2024-10-01 to 2025-06-30 | $58.4m | us-gaap:InterestExpense |
| Income tax | 3 months2025-04-01 to 2025-06-30 | $8.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-10-01 to 2025-06-30 | $20.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-04-01 to 2025-06-30 | $29.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-10-01 to 2025-06-30 | $56.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-04-01 to 2025-06-30 | $0.62 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-10-01 to 2025-06-30 | $1.17 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-04-01 to 2025-06-30 | $0.62 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-10-01 to 2025-06-30 | $1.17 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-04-01 to 2025-06-30 | 47,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-10-01 to 2025-06-30 | 48,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-10-01 to 2025-06-30 | $44.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-10-01 to 2025-06-30 | $49.4m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2024-10-01 to 2025-06-30 | $22.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2024-10-01 to 2025-06-30 | $90.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2025-06-30 | $1.00bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-06-30 | $3.79bn | us-gaap:Assets |
| Current liabilities | At period end2025-06-30 | $567.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-06-30 | $2.23bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-06-30 | $1.37bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2025-06-30 | $1.57bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-25-037827. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.